Showing 1 - 5 results of 5 for search 'Sijana H Dzinic', query time: 0.02s
Refine Results
-
1
Identification of an intrinsic determinant critical for maspin subcellular localization and function. by Sijana H Dzinic, Alexander Kaplun, Xiaohua Li, Margarida Bernardo, Yonghong Meng, Ivory Dean, David Krass, Paul Stemmer, Namhee Shin, Fulvio Lonardo, Shijie Sheng
Published 2013-01-01
Article -
2
Cotargeting of Mitochondrial Complex I and Bcl-2 Shows Antileukemic Activity against Acute Myeloid Leukemia Cells Reliant on Oxidative Phosphorylation by Fangbing Liu, Hasini A. Kalpage, Deying Wang, Holly Edwards, Maik Hüttemann, Jun Ma, Yongwei Su, Jenna Carter, Xinyu Li, Lisa Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Guan Wang, Jeffrey W. Taub, Yubin Ge
Published 2020-08-01
Article -
3
Targeted therapy of pyrrolo[2,3-d]pyrimidine antifolates in a syngeneic mouse model of high grade serous ovarian cancer and the impact on the tumor microenvironment by Adrianne Wallace-Povirk, Lisa Rubinsak, Agnes Malysa, Sijana H. Dzinic, Manasa Ravindra, Mathew Schneider, James Glassbrook, Carrie O’Connor, Zhanjun Hou, Seongho Kim, Jessica Back, Lisa Polin, Robert T. Morris, Aleem Gangjee, Heather Gibson, Larry H. Matherly
Published 2022-07-01
Article -
4
Maspin differential expression patterns as a potential marker for targeted screening of esophageal adenocarcinoma/gastroesophageal junction adenocarcinoma. by Sijana H Dzinic, Zaid Mahdi, M Margarida Bernardo, Semir Vranic, Haya Beydoun, Nadine Nahra, Amra Alijagic, Deanna Harajli, Aaron Pang, Dan M Saliganan, Abid M Rahman, Faruk Skenderi, Berisa Hasanbegovic, Gregory Dyson, Rafic Beydoun, Shijie Sheng
Published 2019-01-01
Article -
5
The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML by Xinan Qiao, Jun Ma, Tristan Knight, Yongwei Su, Holly Edwards, Lisa Polin, Jing Li, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Jian Wang, Hai Lin, Yue Wang, Liping Wang, Guan Wang, Jeffrey W. Taub, Yubin Ge
Published 2021-06-01
Article